Farther Finance Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$878K Buy
10,178
+211
+2% +$17.6K 0.01% 1211
2026
Q2
$672K Buy
9,967
+7
+0.1% +$466 0.01% 1340
2026
Q1
$621K Buy
9,960
+5,583
+128% +$389K 0.01% 1251
2025
Q4
$291K Buy
4,377
+992
+29% +$64.1K ﹤0.01% 1663
2025
Q3
$228K Sell
3,385
-295
-8% -$23.3K ﹤0.01% 1538
2025
Q2
$321K Buy
3,680
+580
+19% +$45.5K 0.01% 1149
2025
Q1
$209K Buy
3,100
+702
+29% +$57.3K 0.01% 1208
2024
Q4
$186K Sell
2,398
-170
-7% -$12.6K 0.01% 1016
2024
Q3
$172K Buy
2,568
+1,134
+79% +$93.1K 0.01% 1052
2024
Q2
$161K Buy
1,434
+64
+5% +$8.09K 0.01% 935
2024
Q1
$189K Buy
1,370
+28
+2% +$3.52K 0.01% 704
2023
Q4
$167K Buy
1,342
+859
+178% +$87.8K 0.01% 616
2023
Q3
$45.1K Buy
483
+139
+40% +$15.7K 0.01% 804
2023
Q2
$44.2K Buy
344
+4
+1% +$484 0.01% 720
2023
Q1
$39.5K Buy
340
+202
+146% +$22.6K 0.01% 676
2022
Q4
$15.6K Buy
+138
New +$15.2K 0.01% 812

Other funds holding DXCM

Farther Finance Advisors's DXCM Position: Q3 2026 in Review

Farther Finance Advisors increased its DexCom (DXCM) stake by 2.1% in Q3 2026, buying an estimated $17.6K and bringing the position to 10,178 shares worth $878K. The position accounts for 0.01% of the portfolio, ranked #1211.

Farther Finance Advisors first reported a position in DXCM in Q4 2022 and has held it in 16 quarters since. 41 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Farther Finance Advisors held 10,178 shares of DexCom worth $878K as of Q3 2026.
  • Farther Finance Advisors bought 211 DexCom shares in Q3 2026, an estimated $17.6K.
  • DexCom made up 0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1211 holding.
  • Farther Finance Advisors first reported a position in DexCom in Q4 2022 and has held it in 16 quarters since.
  • 41 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.